| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.0M | -24.7% |
| R&D Expense | $12.2M | -23.4% |
| SG&A Expense | $17.4M | -35.5% |
| Operating Income | -$21.3M | +31.1% |
| Interest Expense | $2.2M | -49.4% |
| Net Income | -$24.5M | +30.2% |
| EPS (Basic) | -$0.72 | +44.6% |
| EPS (Diluted) | -$0.72 | +44.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $34.3M | +117.6% |
| Current Assets | $39.1M | -47.4% |
| Total Assets | $44.7M | -44.2% |
| Current Liabilities | $3.5M | -92.5% |
| Total Liabilities | $4.7M | -90.1% |
| Stockholders' Equity | $40.0M | +22.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.6M | +32.4% |
| Capital Expenditures | $302K | -65.8% |
| Investing Cash Flow | $54.0M | +5514.9% |
| Financing Cash Flow | -$16.9M | -150.1% |
| Free Cash Flow | -$19.0M | +33.4% |